The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia

We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2023, Vol.174 (3), p.304-307
Hauptverfasser: Naryzhnaya, N. V., Sementsov, A. S., Maslov, L. N., Derkachev, I. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 307
container_issue 3
container_start_page 304
container_title Bulletin of experimental biology and medicine
container_volume 174
creator Naryzhnaya, N. V.
Sementsov, A. S.
Maslov, L. N.
Derkachev, I. A.
description We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.
doi_str_mv 10.1007/s10517-023-05696-3
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2771637628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A744168313</galeid><sourcerecordid>A744168313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</originalsourceid><addsrcrecordid>eNp9klFrFDEUhQdR7Fr9Az5IQBBfpia5mcns47JUW1ha0PY5ZDJ3dlNmkjXJQPffm3GrtSKSh5Dc7xzuTU5RvGX0jFEqP0VGKyZLyqGkVb2sS3hWLFgloWw4Z8-LBc1UKZqmOSlexXg3H2nNXhYnUEsOEsSiGG92SL76AYnvydU1-XZwaacjEutIyqVL1-tgUrmxo03Wbcl536NJM30btugS0a4j613wzhqy6vQ-6WR9Fnty5cPoWx1y4eKw9_dWvy5e9HqI-OZhPy1uP5_frC_KzfWXy_VqUxqoRCpNpTlfCgYVMG1a1kJTY6N5zRFMK7AG6CkiZ6YFIwEltF3fYptx0QmxhNPi49F3H_z3CWNSo40Gh0E79FNUXEpWg6x5k9H3f6F3fgoudzdTQtKGVeyR2uoBlXW9T0Gb2VStpBCsboBBps7-QeXV4WiNd9jbfP9E8OEPwQ71kHbRD9P8gvEpyI-gCT7GgL3aBzvqcFCMqjkM6hgGlcOgfoZBzaJ3D6NN7Yjdb8mv388AHIGYS26L4XH2_9j-AFIVu8U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2774708151</pqid></control><display><type>article</type><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</creator><creatorcontrib>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</creatorcontrib><description>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-023-05696-3</identifier><identifier>PMID: 36723734</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analysis ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Coronary artery ; General Pathology and Pathological Physiology ; Heart ; Hemoglobin ; Hypoxia ; Internal Medicine ; Ischemia ; Laboratory Medicine ; Male ; Myocardial Infarction ; Myocardial Reperfusion Injury - drug therapy ; NG-Nitroarginine methyl ester ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide Synthase ; Pathology ; Physiology ; Rats ; Rats, Wistar ; Reperfusion</subject><ispartof>Bulletin of experimental biology and medicine, 2023, Vol.174 (3), p.304-307</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10517-023-05696-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10517-023-05696-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36723734$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Naryzhnaya, N. V.</creatorcontrib><creatorcontrib>Sementsov, A. S.</creatorcontrib><creatorcontrib>Maslov, L. N.</creatorcontrib><creatorcontrib>Derkachev, I. A.</creatorcontrib><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</description><subject>Analysis</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Coronary artery</subject><subject>General Pathology and Pathological Physiology</subject><subject>Heart</subject><subject>Hemoglobin</subject><subject>Hypoxia</subject><subject>Internal Medicine</subject><subject>Ischemia</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Myocardial Infarction</subject><subject>Myocardial Reperfusion Injury - drug therapy</subject><subject>NG-Nitroarginine methyl ester</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide Synthase</subject><subject>Pathology</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reperfusion</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9klFrFDEUhQdR7Fr9Az5IQBBfpia5mcns47JUW1ha0PY5ZDJ3dlNmkjXJQPffm3GrtSKSh5Dc7xzuTU5RvGX0jFEqP0VGKyZLyqGkVb2sS3hWLFgloWw4Z8-LBc1UKZqmOSlexXg3H2nNXhYnUEsOEsSiGG92SL76AYnvydU1-XZwaacjEutIyqVL1-tgUrmxo03Wbcl536NJM30btugS0a4j613wzhqy6vQ-6WR9Fnty5cPoWx1y4eKw9_dWvy5e9HqI-OZhPy1uP5_frC_KzfWXy_VqUxqoRCpNpTlfCgYVMG1a1kJTY6N5zRFMK7AG6CkiZ6YFIwEltF3fYptx0QmxhNPi49F3H_z3CWNSo40Gh0E79FNUXEpWg6x5k9H3f6F3fgoudzdTQtKGVeyR2uoBlXW9T0Gb2VStpBCsboBBps7-QeXV4WiNd9jbfP9E8OEPwQ71kHbRD9P8gvEpyI-gCT7GgL3aBzvqcFCMqjkM6hgGlcOgfoZBzaJ3D6NN7Yjdb8mv388AHIGYS26L4XH2_9j-AFIVu8U</recordid><startdate>2023</startdate><enddate>2023</enddate><creator>Naryzhnaya, N. V.</creator><creator>Sementsov, A. S.</creator><creator>Maslov, L. N.</creator><creator>Derkachev, I. A.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2023</creationdate><title>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</title><author>Naryzhnaya, N. V. ; Sementsov, A. S. ; Maslov, L. N. ; Derkachev, I. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-c5a229413531acb1b386e8a262e3cb4e633f0ee21cb3c73e73bdfbeb5314d4493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Coronary artery</topic><topic>General Pathology and Pathological Physiology</topic><topic>Heart</topic><topic>Hemoglobin</topic><topic>Hypoxia</topic><topic>Internal Medicine</topic><topic>Ischemia</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Myocardial Infarction</topic><topic>Myocardial Reperfusion Injury - drug therapy</topic><topic>NG-Nitroarginine methyl ester</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide Synthase</topic><topic>Pathology</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reperfusion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naryzhnaya, N. V.</creatorcontrib><creatorcontrib>Sementsov, A. S.</creatorcontrib><creatorcontrib>Maslov, L. N.</creatorcontrib><creatorcontrib>Derkachev, I. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naryzhnaya, N. V.</au><au>Sementsov, A. S.</au><au>Maslov, L. N.</au><au>Derkachev, I. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2023</date><risdate>2023</risdate><volume>174</volume><issue>3</issue><spage>304</spage><epage>307</epage><pages>304-307</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><abstract>We studied the role of NO synthase in the infarct-limiting effect of short-term (SNH) and chronic continuous normobaric hypoxia (CNH). In male Wistar rats, SNH (6 sessions of 10-min hypoxia 8% O2 and 10-min reoxygenation) or CNH (12% O2 for 21 days) was modeled. In 30 min after SNH or 24 h after CNH, the rats were subjected to coronary artery occlusion (45 min) and reperfusion (2 h). The following drugs were administered to rats: non-selective NO synthase inhibitor L-NAME (10 mg/kg), inhibitor of inducible NO synthase S-methylthiourea (3 mg/kg), and inhibitor of neuronal NO-synthase 7-nitroindazole (50 mg/kg). NO donor diethylenetriamine was administered intravenously in a dose 2 mg/kg. It was found that L-NAME and S-methylthiourea abolished the infarct-limiting effect of SNH and CNH. Diethylenetriamine increased cardiac tolerance to ischemia/reperfusion. It is believed that inducible NO synthase plays an important role in the cardioprotective effect of normobaric hypoxia.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36723734</pmid><doi>10.1007/s10517-023-05696-3</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-4888
ispartof Bulletin of experimental biology and medicine, 2023, Vol.174 (3), p.304-307
issn 0007-4888
1573-8221
language eng
recordid cdi_proquest_miscellaneous_2771637628
source MEDLINE; SpringerNature Journals
subjects Analysis
Animals
Biomedical and Life Sciences
Biomedicine
Cell Biology
Coronary artery
General Pathology and Pathological Physiology
Heart
Hemoglobin
Hypoxia
Internal Medicine
Ischemia
Laboratory Medicine
Male
Myocardial Infarction
Myocardial Reperfusion Injury - drug therapy
NG-Nitroarginine methyl ester
NG-Nitroarginine Methyl Ester - pharmacology
Nitric Oxide Synthase
Pathology
Physiology
Rats
Rats, Wistar
Reperfusion
title The Role of NO Synthase in the Infarct-Limiting Effect of Urgent and Chronic Adaptation to Normobaric Hypoxia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20NO%20Synthase%20in%20the%20Infarct-Limiting%20Effect%20of%20Urgent%20and%20Chronic%20Adaptation%20to%20Normobaric%20Hypoxia&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Naryzhnaya,%20N.%20V.&rft.date=2023&rft.volume=174&rft.issue=3&rft.spage=304&rft.epage=307&rft.pages=304-307&rft.issn=0007-4888&rft.eissn=1573-8221&rft_id=info:doi/10.1007/s10517-023-05696-3&rft_dat=%3Cgale_proqu%3EA744168313%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2774708151&rft_id=info:pmid/36723734&rft_galeid=A744168313&rfr_iscdi=true